 5, 6, 7, 8 
Introduction
Many chronic diseases are now in pandemic proportions and increasingly a major cause of morbidity and mortality worldwide. Diabetes mellitus, especially type 2 diabetes, plays a starring role in this problem, 1, 2 with diabetic complications being a very important public health issue.. A paradigmatic example of diabetic complications is diabetic nephropathy, the largest single cause of end-stage renal disease (5-10% of type 2 diabetic patients will develop ESRD from diabetic nephropathy (DN)2, and a med According to the Diabetes Atlas 2006 published by the Intemational Diabetes Federation, the number of people with diabetes in India currently around 40.9 million is expected to rise to 69.9 million by 2025 unless urgent preventive steps are taken. Diabetic patients in developing countries because of Asian Indian phenotype (which include increased insulin resistance, greater abdominal adiposity i.e., higher waist circmnference despite lower body mass index, lower adiponectin) are even more vulnerable to develop the micro-vascular complications of diabetes including diabetic nephropathy. 5, 8, 9 Patients with type 2 diabetes comprise the largest and fastest growing single disease group requiring renal replacement therapy (nearly 50-60% of diabetic subjects receiving renal replacement therapy. 6 Studies based in southern India have estimated that the current prevalence of o Several recent studies have also shown that patients with type 2 DM and overt nephropathy exhibit high levels of diverse acute phase markers of inflammation, including C-reactive protein (CRP), serum amyloid A, fibrinogen, and IL. It is well known that in the general population, as well as in diabetes, these acute-phase markers are associated with increased cardiovascular risk, because chronic inflammation is one of the pathogenetic mechanisms of atherosclerosis 11 , 12,13 . In contrast, the relationships between low grade inflammation and diabetic microangiopathy are still unclear. As far as nephropathy is concerned, several studies have examined the relationships with inflammation, leading to conflicting results 23 . Overall, however, most studies have reported an increase in acute-phase markers in patients with nephropathy and also in patients with microalbuminuria 18'20'22' This study Was undertaken to investigate the role of subclinical inflammation in the pathogenesis of diabetic nephropathy by evaluating the association between the serum High-sensitivity CRP (HS-CRP) (marker of inflammation) and urinary albumin to creatinine ratio(UACR) in type2 diabetes mellitus.
II. Material And Methods
A prospective case control study of 100 diabetic patients were taken(50 patients with nephropathy and 50 without nephropathy) all these patients hsCRP was compared with UACR(urine albumin to urine creatine ratio) All subjects were submitted to the following: 
IV. Discussion
100 Type 2 Diabetes Mellitus patients with age 18 and above to the department of medicine and were divided into 2 groups based on UACR. One group consisted of 50 Type 2 Diabetes Mellitus with UACR <3mg/dl. Other group consisted of 50 Type 2 Diabetes Mellitus patient with UACR>3mg/dl. HsCRP was studied in all of them in correlation with UACR. Although there is now convincing evidence that Type 2 Diabetes Mellitus includes an inflammatory component that has been related to diabetic complications. There is limited data on Type 2 Diabetes Mellitus Nephropathy in Asia .In order to find an easier method for detection of diabetic nephropathy as a screening method of diabetic nephropathy we tried to find a relation between hsCRP as a marker of diabetic nephropathy. In this study, the mean age of patients without nephropathy was 57.14 and mean age of patients with nephropathy was 55.7.In one study by Nikhil Choudhary, Ravinder S Ahlawat the mean age was 55.05±7 and 57 ±4 in patients with micro and macro albuminuria respectively 10.
Hs-CRP and Diabetic Nephropathy
In our study we found that diabetic patients with nephropathy showed significantly higher levels of Hs-CRP. This result is in agreement with Picardi et al14, 15 who reported that patients with recent onset of type 2 DM with nephropathy had higher levels of Hs-CRP as compared to patients without nephropathy 15 . Also, Coulon et al 16 proved that diabetic patients have higher levels of cytokines than normal individuals and this elevation might be related to activation of macrophages, increased oxidative stress, or induction of cytokines. So, type2 DM is now accepted to be a chronic immuno-inflammatory disorder. However, Alexandraki et al 17 did not find any significant difference between 167 type 2 diabetic patients and control group as regards IL-6. In our study we found that low-grade inflammation was already present in the early stage of microalbuminuria, and it was increased with progressive increase of UAE. In agreement with our results, Picardi et al 15 and Piccirillo et al 18 who observed that low-grade inflammation was already present in the early stage of micro-albuminuria and low-grade inflammatory markers could serve in predicting initiation, and the progression of diabetic nephropathy. Also Saraheimo et al 19 reported that low-grade inflammatory markers are associated with diabetic nephropathy in type 2 diabetic patients in which C-reactive protein and interleukin-6 were higher compared to normoalbuminuric patients. On the other hand, contradictory study showed higher CRP concentrations in patients with normoalbuminuria than macroalbuminuria 20, 21 . So, the results are conflicting and needs further research to clarify the role of these inflammatory cytokines in diabetic complications. In addition, we found that the level of HbA1c at baseline showed a significant positive correlation with Hs-CRP (r = 0.750, p < 0.001), in the diabetic group.. Also, we found a significant direct correlation between blood pressure and Hs-CRP and IL-6.. In addition, a study 20 included 45 consecutive young patients with type 2 diabetes, followed up at a public health assistance centre, and 30 healthy subjects matched by age revealed that inflammatory markers especially CRP are more higher in diabetic hypertensive patients more than normotensive diabetic patients By doing stepwise multiple regression analysis to determine the independent association between potential predictor variables (age, duration of diabetes, waist circumference, CRP level, at baseline), the UAE was the dependent variable, after adjusting for the effect of other variables by partial correlation analysis. Association between UAE and the levels of inflammatory markers of Hs-CRP with R² = 0.927 (p < 0.001) and IL-6 with R² = 0.838 (p < 0.001) was found.
